Use of oral vitamin K for prevention of late vitamin K deficiency bleeding in neonates when injectable vitamin K is not available;Uso profiláctico de vitamina K oral para la hemorragia por deficiencia de vitamina K tardía en neonatos cuando la vitamina K inyectable no está disponible

Annals of Pharmacotherapy

Volumn 46, Issue 6, 2012, Pages 879-883

  Ipema Dr , Heather J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Drug shortage; Neonate; Newborn; Oral; Prophylaxis; Vitamin K deficiency bleeding

Indexed keywords

VITAMIN K GROUP;

ARTICLE; AUSTRALIA; BREAST FEEDING; DENMARK; DRUG EFFICACY; DRUG USE; GERMANY; HIGH RISK PATIENT; HUMAN; INCIDENCE; NETHERLANDS; NEWBORN HEMORRHAGIC DISEASE; PARENTAL ATTITUDE; PRIORITY JOURNAL; PROPHYLAXIS; SWITZERLAND; TREATMENT DURATION;

ADMINISTRATION, ORAL; HUMANS; INCIDENCE; INFANT, NEWBORN; INJECTIONS; VITAMIN K; VITAMIN K DEFICIENCY BLEEDING;

EID: 84862255971     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q769     Document Type: Article

References (20)

1. Tandoi F, Mosca F, Agosti M. Vitamin K prophylaxis: leaving the old route for the new one? Acta Paediatr Suppl 2005;94:125-8. DOI 10.1080/08035320510043682
2. Shearer MJ. Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev 2009;23:49-59. DOI 10.1016/j.blre.2008.06.001
3. Sutor AH, von Kries R, Cornelissen EAM, McNinch AQ, Andrew M. Vitamin K deficiency bleeding (VKDB) in infancy. Thromb Haemost 1999;81:456-61.
4. American Academy of Pediatrics Committee on Fetus and Newborn. Controversies concerning vitamin K and the newborn. Pediatrics 2003; 112:191-2.
5. Autret-Leca E, Jonville-Bera AP. Vitamin K in neonates: how to administer, when and to whom. Paediatr Drugs 2001;3:1-8.
6. Brousson MA, Klein MC. Controversies surrounding the administration of vitamin K to newborns: a review. CMAJ 1996;154:307-15.
7. Puckett RM, Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database Syst Rev 2000;4: CD002776. DOI 10.1002/14651858.CD002776
8. Hansen KN, Minousis M, Ebbesen F. Weekly oral vitamin K prophylaxis in Denmark. Acta Paediatr 2003;92:802-5.
9. Cornelissen M, von Kries R, Loughnan P, Schubiger G. Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Pediatr 1997;156:126-30.
10. Ijland MM, Pereira RR, Cornelissen EA. Incidence of late vitamin K deficiency bleeding in newborns in the Netherlands in 2005: evaluation of the current guideline. Eur J Pediatr 2008;167:165-9. DOI 10.1007/s00431-007-0443-x
11. Doran O, Austin NC, Taylor BJ. Vitamin K administration in neonates: survey of compliance with recommended practices in the Dunedin area. N Z Med J 1995;108:337-9.
12. van Hasselt PM, de Koning TJ, Kvist N, et al. Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries. Pediatrics 2008;121: e857-63. DOI 10.1542/peds.2007-1788
13. van Winckel M, de Bruyne R, van de Velde S, van Biervliet S. Vitamin K, an update for the paediatrician. Eur J Pediatr 2009;168:127-34. DOI 10.1007/s00431-008-0856-1
14. Clarke P. Vitamin K prophylaxis for preterm infants. Early Hum Dev 2010; 86:17-20. DOI 10.1016/j.earlhumdev.2010.01.013
15. Crowther CA, Crosby DD, Henderson-Smart DJ. Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage. Cochrane Database Syst Rev 2010;1:CD000229. DOI 10.1002/14651858.CD000229.pub2
16. Taketomo CK, Hodding JH, Kraus DM. Pediatric and neonatal dosage handbook. 18th ed. Hudson, OH: Lexi-Comp, 2011.
17. Nahata MC, Pai VB, Hipple TF. Pediatric drug formulations. 5th ed. Cincinnati, OH: Harvey Whitney Books Company, 2004.
18. Phytonadione (vitamin K). Drug facts and comparisons. St. Louis, MO: Wolters Kluwer Health. http://online.factsandcomparisons.com (accessed 2011 Dec 30).
19. 2011 Red book online. Montvale, NJ: PDR Network, LCC. www.thomsonhc.com (accessed 2011 Dec 30).
20. Food and Drug Administration. Orange book: approved drug products with therapeutic equivalence evaluations. http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm (accessed 2011 Dec 30).